The Impact of Delayed Switch to Second-Line Antiretroviral Therapy on Mortality, Depending on Definition of Failure Time and CD4 Count at Failure

Little is known about the functional relationship of delaying second-line treatment initiation for human immunodeficiency virus–positive patients and mortality, given a patient’s immune status. We included 7,255 patients starting antiretroviral therapy during 2004–2017, from 9 South African cohorts,...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Am J Epidemiol
Asıl Yazarlar: Bell-Gorrod, Helen, Fox, Matthew P, Boulle, Andrew, Prozesky, Hans, Wood, Robin, Tanser, Frank, Davies, Mary-Ann, Schomaker, Michael
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Oxford University Press 2020
Konular:
Original Contribution
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7523585/
https://ncbi.nlm.nih.gov/pubmed/32219384
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/aje/kwaa049
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller